JP7562542B2 - 真菌性骨－関節感染症を治療するためのトリテルペノイド系抗真菌薬 - Google Patents

真菌性骨－関節感染症を治療するためのトリテルペノイド系抗真菌薬 Download PDF

Info

Publication number
JP7562542B2
JP7562542B2 JP2021544218A JP2021544218A JP7562542B2 JP 7562542 B2 JP7562542 B2 JP 7562542B2 JP 2021544218 A JP2021544218 A JP 2021544218A JP 2021544218 A JP2021544218 A JP 2021544218A JP 7562542 B2 JP7562542 B2 JP 7562542B2
Authority
JP
Japan
Prior art keywords
formula
compound
bone
pharma
fungal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021544218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022519500A5 (https=
JP2022519500A (ja
JPWO2020160316A5 (https=
Inventor
アングロ・ゴンザレス，デイビット・エー
Original Assignee
サイネクシス，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サイネクシス，インコーポレーテッド filed Critical サイネクシス，インコーポレーテッド
Publication of JP2022519500A publication Critical patent/JP2022519500A/ja
Publication of JP2022519500A5 publication Critical patent/JP2022519500A5/ja
Publication of JPWO2020160316A5 publication Critical patent/JPWO2020160316A5/ja
Application granted granted Critical
Publication of JP7562542B2 publication Critical patent/JP7562542B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
JP2021544218A 2019-01-30 2020-01-30 真菌性骨－関節感染症を治療するためのトリテルペノイド系抗真菌薬 Active JP7562542B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962798743P 2019-01-30 2019-01-30
US62/798,743 2019-01-30
PCT/US2020/015948 WO2020160316A1 (en) 2019-01-30 2020-01-30 Triterpenoid antifungals for the treatment of fungal osteo-articular infections

Publications (4)

Publication Number Publication Date
JP2022519500A JP2022519500A (ja) 2022-03-24
JP2022519500A5 JP2022519500A5 (https=) 2023-04-10
JPWO2020160316A5 JPWO2020160316A5 (https=) 2023-04-10
JP7562542B2 true JP7562542B2 (ja) 2024-10-07

Family

ID=69740705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021544218A Active JP7562542B2 (ja) 2019-01-30 2020-01-30 真菌性骨－関節感染症を治療するためのトリテルペノイド系抗真菌薬

Country Status (7)

Country Link
US (2) US20220117948A1 (https=)
EP (1) EP3917534B1 (https=)
JP (1) JP7562542B2 (https=)
CN (1) CN113498343A (https=)
EA (1) EA202192107A1 (https=)
MA (1) MA54866A (https=)
WO (1) WO2020160316A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020276595B2 (en) * 2019-05-16 2025-12-04 Scynexis, Inc. Antifungal Agents for Candida Auris Decolonization

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010019203A1 (en) 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
JP2011530593A (ja) 2008-08-12 2011-12-22 メルク・シャープ・エンド・ドーム・コーポレイション 抗真菌剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
JP5245057B2 (ja) 2006-04-03 2013-07-24 メルク・シャープ・アンド・ドーム・コーポレーション 抗真菌剤
WO2018102407A1 (en) * 2016-11-29 2018-06-07 Cidara Therapeutics, Inc Methods for preventing fungal infections

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010019203A1 (en) 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
JP2011530593A (ja) 2008-08-12 2011-12-22 メルク・シャープ・エンド・ドーム・コーポレイション 抗真菌剤

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis，Antimicrobial Agents and Chemotherapy，2017年，vol.61, no.4，pp.1-15，https://doi.org/ 10.1128/AAC.02068-16，e02068-16
SCY-078 Demonstrates Significant Tissue Penetration in Rats and Mice Following Oral or IV Administration，Open Forum Infectious Diseases，2017年，4(Suppl 1)，S471，10.1093/ofid/ofx163.1204，1508
SCY-078, a Novel Fungicidal Agent, Demonstrates Distribution to Tissues Associated with Fungal Infections during Mass Balance Studies with Intravenous and Oral [14C] SCY-078 in Albino and Pigmented Rats，Antimicrobial Agents and Chemotherapy，2019年01月29日，vol.63, no.2，pp.1-9，https://doi.org/10.1128/AAC.02119-18，e02119-18

Also Published As

Publication number Publication date
US20220117948A1 (en) 2022-04-21
EA202192107A1 (ru) 2021-10-21
MA54866A (fr) 2022-05-04
JP2022519500A (ja) 2022-03-24
CN113498343A (zh) 2021-10-12
EP3917534A1 (en) 2021-12-08
US20250248983A1 (en) 2025-08-07
EP3917534B1 (en) 2024-07-03
WO2020160316A1 (en) 2020-08-06

Similar Documents

Publication Publication Date Title
US20260000656A1 (en) Antifungal agents with enhanced activity in acidic ph
US20250248983A1 (en) Triterpenoid antifungals for the treatment of fungal osteo-articular infections
JP2020513037A (ja) 併用される抗真菌剤
IL288165B1 (en) Antifungal agents for decolonization of Candida auris
HK40062374A (en) Triterpenoid antifungals for the treatment of fungal osteo-articular infections
HK40062374B (en) Triterpenoid antifungals for the treatment of fungal osteo-articular infections
EA051506B1 (ru) Тритерпеноидные фунгициды для лечения грибковых костно-суставных инфекций
JP7581219B2 (ja) ニューモシスチス属種（Ｐｎｅｕｍｏｃｙｓｔｉｓ ｓｐｐ．）肺炎を治療又は予防するためのトリテルペノイド系抗真菌薬
HK40091926A (en) Antifungal agents with enhanced activity in acidic ph
HK40030410B (en) Antifungal agents with enhanced activity in acidic ph
HK40030410A (en) Antifungal agents with enhanced activity in acidic ph
HK40066679A (en) Triterpenoid antifungals for the treatment of pneumocystis spp. pneumonia
HK40066679B (en) Triterpenoid antifungals for the treatment of pneumocystis spp. pneumonia
EA047126B1 (ru) Противогрибковое средство для лечения или профилактики инфекции вульвовагинального кандидоза

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230331

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240716

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240827

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240925

R150 Certificate of patent or registration of utility model

Ref document number: 7562542

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150